FDA Drug Class II — Moderate

CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.

Hazard

Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.

Products

CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
Brand
AbbVie Inc
UPC
Lot #: 1020156; Expiry: 3/31/2016

Units Affected

18,021 Bottles